SCHEMBL1017104

SCHEMBL1017104

Cc1cc(C)cc(-c2ccc3c(c2)CCN(CC(=O)N2CCN(C(C)C)CC2)C3)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
PKM P14618 2/20 0.44
KDM4E B2RXH2 2/20 0.44
TSHR P16473 1/20 0.44
HRH3 Q9Y5N1 5/20 0.42
GAA P10253 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KCNH2 Q12809 2/20 0.40
PRMT5 O14744 2/20 0.37
WDR77 Q9BQA1 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ACACB O00763 4/20 0.37
CD274 Q9NZQ7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1017851 0.93 MEN1 (0.49) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1017273 0.89 HRH3 (0.42) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1018706 0.87 ACACB (0.43) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1017932 0.86 MAPT (0.44) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1018776 0.85 HRH3 (0.41) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1014831 0.85 PRMT5 (0.46) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1018762 0.85 RAB9A (0.45) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1017737 0.85 HRH3 (0.46) ALDH1A1MEN1KMT2APKMKDM4E
SCHEMBL1604050 0.85 ALDH1A1 (0.50) ALDH1A1KMT2AKDM4EHRH3GAA
SCHEMBL1020441 0.85 ALDH1A1 (0.50) ALDH1A1KMT2AKDM4EHRH3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US claimed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 ALDH1A1 1229/4885MEN1 2317/4885KMT2A 566/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 ALDH1A1 1229/4885MEN1 2317/4885KMT2A 566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.